Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

Nadine Abdallah; Thomas E. Witzig; Shaji K. Kumar; Martha Q. Lacy; Suzanne R. Hayman; Angela Dispenzieri; Vivek Roy; Morie A. Gertz; P. Leif Bergsagel; S. Vincent Rajkumar

doi:10.1038/s41375-024-02192-z

Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

Nadine Abdallah, Thomas E. Witzig, Shaji K. Kumar, Martha Q. Lacy, Suzanne R. Hayman, Angela Dispenzieri, Vivek Roy, Morie A. Gertz, P. Leif Bergsagel, S. Vincent Rajkumar

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Leukemia
DOIs	https://doi.org/10.1038/s41375-024-02192-z
State	Accepted/In press - 2024

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-024-02192-z

Cite this

@article{7dcd0887412c4b94b0cfcd9c6e38491f,

title = "Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up",

author = "Nadine Abdallah and Witzig, {Thomas E.} and Kumar, {Shaji K.} and Lacy, {Martha Q.} and Hayman, {Suzanne R.} and Angela Dispenzieri and Vivek Roy and Gertz, {Morie A.} and Bergsagel, {P. Leif} and Rajkumar, {S. Vincent}",

year = "2024",

doi = "10.1038/s41375-024-02192-z",

language = "English (US)",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

AU - Abdallah, Nadine

AU - Witzig, Thomas E.

AU - Kumar, Shaji K.

AU - Lacy, Martha Q.

AU - Hayman, Suzanne R.

AU - Dispenzieri, Angela

AU - Roy, Vivek

AU - Gertz, Morie A.

AU - Bergsagel, P. Leif

AU - Rajkumar, S. Vincent

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85186179428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186179428&partnerID=8YFLogxK

U2 - 10.1038/s41375-024-02192-z

DO - 10.1038/s41375-024-02192-z

M3 - Letter

AN - SCOPUS:85186179428

SN - 0887-6924

JO - Leukemia

JF - Leukemia

ER -

Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this